Gynecologic Oncology

Gynecol Oncol · ISSN (print) 0090-8258 · ISSN (e) 1095-6859 · 339 papers in corpus
observational 2012
doi:10.1016/j.ygyno.2012.03.009 ·PMID:22425664

OBJECTIVE: To evaluate the utility of peritoneal washing cytology (PWC) for detecting occult primary peritoneal carcinoma in patients with BRCA1 or BRCA2 mutations, we reviewed PWCs obtained during risk-reducing salpingo-oophorectomy (RRSO)…

other 2012
doi:10.1016/j.ygyno.2012.12.037 ·PMID:23283299

OBJECTIVE: To analyze the outcomes of second round of fertility-sparing management using progestin in patients with recurrent endometrial cancer after successful fertility-sparing management using progestin. METHODS: We reviewed 45 patient…

observational 2012
doi:10.1016/j.ygyno.2012.05.037 ·PMID:22668880

OBJECTIVE: To determine perioperative risk factors for prolonged hospitalization after gynecologic laparoscopic surgery. METHODS: Data on patients who underwent gynecologic laparoscopic surgery at a single academic institution from January…

observational 2012
doi:10.1016/j.ygyno.2012.03.011 ·PMID:22426487

OBJECTIVE: Human epididymal secretory protein E4 (HE4) is a new promising tumor marker developed for the diagnostics and follow up of ovarian cancer. It has yet to become widely accepted in clinical practice, and its biological properties h…

other 2012
doi:10.1016/j.ygyno.2011.10.032 ·PMID:22063459

PURPOSE: Our goal was to determine if symptom-based ovarian cancer screening was feasible in a primary care clinic and acceptable to women and practitioners. In addition, we wanted to describe the outcomes for a pilot group of screened wome…

review 2012
doi:10.1016/j.ygyno.2011.10.001 ·PMID:22032835

OBJECTIVE: This article represents a review of histologic and genetic findings in endometriosis and describes the mechanisms whereby genetic and non-genetic factors potentially contribute to the neoplastic progression of endometriosis. MET…

nonrandomized-trial 2012
doi:10.1016/j.ygyno.2012.11.013 ·PMID:23159815

OBJECTIVE: The objectives of this study are to assess the clinical relevance and validity of the Functional Assessment of Chronic Illness Therapy-Ascites Index (FACIT-AI) in women with ovarian cancer and malignant ascites, and to modify the…

observational 2012
doi:10.1016/j.ygyno.2012.05.007 ·PMID:22609111

OBJECTIVE: Due to the increasing prevalence of the benign condition, ovarian carcinoma arising from endometriosis is emerging as a relevant clinical entity with an unclear biological signature. We have investigated clinical and histologic f…

review 2011
doi:10.1016/j.ygyno.2011.01.005 ·PMID:21276610

OBJECTIVES: Recent literature has highlighted histological types of ovarian carcinoma as distinct diseases, each with unique clinical and molecular features. Historically, the diagnosis of ovarian clear cell carcinoma (CCC) has been of conc…

other 2011
doi:10.1016/j.ygyno.2011.05.034 ·PMID:21684584

OBJECTIVES: Carcinogenesis of the ovary is often associated with endometriosis. We previously demonstrated that antitumor chemokine receptor CXCR3 was upregulated both in endometriosis and ovarian cancers. Currently, little is known about t…

observational 2011
doi:10.1016/j.ygyno.2011.08.022 ·PMID:21925719

OBJECTIVE: To examine the association between gynecological conditions (including uterine fibroids, endometriosis, pelvic inflammatory disease and infections of the tubes/womb), and risk of endometrial cancer overall and by histological sub…

other 2011
doi:10.1016/j.ygyno.2011.01.017 ·PMID:21316748
case-report 2011
doi:10.1016/j.ygyno.2010.10.006 ·PMID:21056460
diagnostic-accuracy 2011
doi:10.1016/j.ygyno.2011.02.022 ·PMID:21420727

OBJECTIVE: About 70% of epithelial ovarian cancer patients (EOC) are diagnosed at advanced stage with a five-year survival rate of only 30%. Whilst CA125 detects peritoneally-spread disease, it has limited sensitivity for early cancers, man…

rct 2011
doi:10.1016/j.ygyno.2010.11.015 ·PMID:21144559

OBJECTIVE: In the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO), ovarian cancer screening with transvaginal ultrasound (TVU) and CA-125 produced a large number of false-positive tests. We examined relationships betwee…

other 2011
doi:10.1016/j.ygyno.2011.02.008 ·PMID:21458039

OBJECTIVES: Complex rectovaginal fistulas repair are extremely challenging. Various surgical options have been suggested; nevertheless, none had been universally accepted as the procedure of choice. This prospective study discusses a novel …

diagnostic-accuracy 2011
doi:10.1016/j.ygyno.2011.06.002 ·PMID:21708402

OBJECTIVE: The low prevalence of ovarian cancer demands both high sensitivity (>75%) and specificity (99.6%) to achieve a positive predictive value of 10% for successful early detection. Utilizing a two stage strategy where serum marker(s) …

review 2011
doi:10.1016/j.ygyno.2011.06.017 ·PMID:21742370

OBJECTIVE: This article critically reviews the literature on the association between endometriosis and gynecological cancers and breast cancer, based on epidemiologic data. METHODS: Literature review of the English language literature base…

observational 2011
doi:10.1016/j.ygyno.2011.06.038 ·PMID:21802715

OBJECTIVE: To explore the association between use of metformin or other antidiabetic drugs and the risk of ovarian cancer. METHODS: Using the UK-based General Practice Research Database, we conducted a case-control analysis to evaluate whe…

observational 2010
doi:10.1016/j.ygyno.2010.08.028 ·PMID:20850174

OBJECTIVE: CA125 at presentation of ovarian cancer carries important prognostic significance; but, other than tumor characteristics, little is known about factors that influence CA125 levels. We examined the effect of epidemiologic variable…

review 2010
doi:10.1016/j.ygyno.2009.09.041 ·PMID:19879639

Each year in the United States over 15,000 women die of epithelial ovarian cancer (EOC) and 22,000 are diagnosed with the disease. The incidence of ovarian cancer has remained stable over the past decade however, survival rates have improve…

other 2010
doi:10.1016/j.ygyno.2010.07.033 ·PMID:20719372
other 2010
doi:10.1016/j.ygyno.2010.05.010 ·PMID:20542546

OBJECTIVE: Endometrial cancer (EC) is the most common gynecologic malignancy. Type I EC has a favorable prognosis, while type II ECs account for half of all treatment failures. Little knowledge of the biological differences is available to …

other 2010
doi:10.1016/j.ygyno.2010.10.036 ·PMID:21130491

OBJECTIVE: Although histological and epidemiological studies have suggested that endometriosis has malignant potential, the molecular mechanism underlying the malignant transformation of endometriosis is poorly understood. Ovarian cancer ar…

observational 2010
doi:10.1016/j.ygyno.2010.05.013 ·PMID:20554314

OBJECTIVE: To determine the risk of malignancy in septated cystic ovarian tumors. MATERIALS: 1319 (4.4%) of 29,829 women were identified by transvaginal sonography (TVS) as having a complex cystic ovarian tumor with septations without soli…